In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis.
about
Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the HaystackAccurate prediction of response to endocrine therapy in breast cancer patients: current and future biomarkersIntratumoral Morphological Heterogeneity of Breast Cancer As an Indicator of the Metastatic Potential and Tumor Chemosensitivity.Comparison of the PI3KCA pathway in circulating tumor cells and corresponding tumor tissue of patients with metastatic breast cancer.RAS pathway biomarkers for breast cancer prognosis.β1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast CancerSIAH and EGFR, Two RAS Pathway Biomarkers, are Highly Prognostic in Locally Advanced and Metastatic Breast CancerEpithelial-mesenchymal plasticity and circulating tumor cells: Travel companions to metastases.Tumour heterogeneity: principles and practical consequences.The promise of circulating tumor cells for precision cancer therapy.Epithelial-mesenchymal plasticity in circulating tumor cells.Enrichment, Isolation and Molecular Characterization of EpCAM-Negative Circulating Tumor Cells.The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy.Molecular characterization of circulating tumor cells from patients with metastatic breast cancer reflects evolutionary changes in gene expression under the pressure of systemic therapy.Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.Critical issues in the clinical application of liquid biopsy in non-small cell lung cancer.Tumor Heterogeneity in Breast Cancer.VSP-17, a New PPARγ Agonist, Suppresses the Metastasis of Triple-Negative Breast Cancer via Upregulating the Expression of E-Cadherin.Development of a Protocol for Single-Cell Analysis of Circulating Tumor Cells in Patients with Solid Tumors.Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncologyAssessment of the Mutational Status of NSCLC Using Hypermetabolic Circulating Tumor Cells
P2860
Q28067549-0439488F-A5AD-4986-B25D-7DD79B56AA92Q28069856-769F68BE-9084-46A8-8461-383E841644C7Q33607816-C70A19CF-4595-4317-94A6-71DFF52966EEQ33674656-680869A3-EB3A-4F88-AB44-E0A6EA567A5CQ33757299-209F01BE-B37D-4388-A8F8-9663AEF51377Q37286353-4FDA9D02-981A-44CA-AC3F-403067A13736Q37309686-586260C6-C72E-4D84-A9D0-08F8E1BF519FQ38838108-9411A5B2-27A9-4FD5-B128-A1C112E4B7E9Q38842168-12259FF5-C9F9-48BB-8925-12B1F7CDE80EQ39031157-345B33D5-A938-411E-AF7A-7223794F7F0DQ39053335-FFB8208D-7707-458D-B4BF-2EC20CC48E6EQ39339880-77EEB666-91E7-4041-A558-6AA9DF7E2EE4Q41036251-5E8963B0-2D1C-4796-A78A-AD0378277C66Q41233528-28FB0E20-876C-4671-B23F-59C5D0532FFAQ42246492-AD46825D-40EC-4E52-AD4C-FD796AD4022CQ47104064-0B760A09-9543-4EEF-A2CE-4E23B41E6785Q47146956-896CD462-74E0-4205-B21F-1454A7466D78Q50116117-4E896FF2-AF54-4A9F-BAB8-8648A0940372Q53738460-80F661AE-AA6D-4C12-8382-97FAD154ECE4Q58695249-F31CE87C-602D-4FEC-9F1E-4EB4C058CB12Q58780366-47A24D6B-4ADE-4479-AF2B-C9620905000A
P2860
In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
In patients with metastatic br ...... ociated with a poor prognosis.
@ast
In patients with metastatic br ...... ociated with a poor prognosis.
@en
type
label
In patients with metastatic br ...... ociated with a poor prognosis.
@ast
In patients with metastatic br ...... ociated with a poor prognosis.
@en
prefLabel
In patients with metastatic br ...... ociated with a poor prognosis.
@ast
In patients with metastatic br ...... ociated with a poor prognosis.
@en
P2093
P2860
P50
P1476
In patients with metastatic br ...... ociated with a poor prognosis.
@en
P2093
Antonio Paolo Beltrami
Barbara Toffoletto
Carla Di Loreto
Carlo Alberto Beltrami
Giacinto Scoles
Marisa Sorrentino
Michela Bulfoni
Miriam Isola
Stefania Marzinotto
P2860
P2888
P356
10.1186/S13058-016-0687-3
P577
2016-03-09T00:00:00Z
P5875
P6179
1021300961